{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T02:21:15Z","timestamp":1780971675066,"version":"3.54.1"},"reference-count":47,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T00:00:00Z","timestamp":1371168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Roche Canada"},{"name":"2012 Canadian Institutes of Health Research (CIHR) New Investigator Award"},{"name":"2011 American Gastroenterology Research Scholar Award"},{"name":"2010 American Association for the Study of Liver Disease (AASLD) Clinical and Translational Research Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background &amp; Aims<\/jats:title><jats:p>Hepatitis B virus (<jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>) genotype and quantitative hepatitis B surface antigen (<jats:styled-content style=\"fixed-case\">qHBsAg<\/jats:styled-content>) have been related to clinical outcome. In this nationwide cross\u2010sectional study, we aimed to investigate the epidemiology and clinical significance of <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> genotype and <jats:styled-content style=\"fixed-case\">qHBsAg<\/jats:styled-content> in patients with chronic hepatitis B (<jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Six hundred and thirty patients with <jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content> were seen in four urban tertiary referral centres in Canada. <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> genotype was determined by line probe assay (INNO\u2010LIPA) and <jats:styled-content style=\"fixed-case\">HBV DNA<\/jats:styled-content> quantified by commercial <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content> (Roche TaqMan, sensitivity &lt;55\u00a0IU\/ml or AMPLICOR, sensitivity &lt;60\u00a0IU\/ml). Titres of <jats:styled-content style=\"fixed-case\">qHBsAg<\/jats:styled-content> were determined by an in\u2010house assay based on the <jats:styled-content style=\"fixed-case\">WHO<\/jats:styled-content> standard (calibration range 0.24\u201362.5\u00a0IU\/ml).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 630 patients (57% male, 69% Asian, median age 42\u00a0years), 21% were hepatitis B e antigen positive and the median alanine aminotransferase was 29\u00a0U\/L. The <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> genotype distribution was A (16%), B (29%), C (31%), D (16%), E (6%). <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> genotype was strongly associated with ethnicity, but neither genotype nor <jats:styled-content style=\"fixed-case\">qHBsAg<\/jats:styled-content> correlated with the degree of fibrosis. In the treatment\u2010na\u00efve patients, the baseline <jats:styled-content style=\"fixed-case\">qHBsAg<\/jats:styled-content> levels correlated with <jats:styled-content style=\"fixed-case\">HBV DNA<\/jats:styled-content> (<jats:italic>r<\/jats:italic>\u00a0=\u00a00.2517, <jats:italic>P\u00a0&lt;\u00a0<\/jats:italic>0.0008). The median <jats:styled-content style=\"fixed-case\">qHBsAg<\/jats:styled-content> levels were lowest in patients with genotype B (<jats:italic>P\u00a0&lt;\u00a0<\/jats:italic>0.0001), but no significant correlation was noted with all other <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> genotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this large North American <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> epidemiological study, genotypes B and C were the most common; however, all genotypes (A\u2013E) were observed with varied distribution nationwide. Baseline <jats:styled-content style=\"fixed-case\">qHBsAg<\/jats:styled-content> significantly correlated with <jats:styled-content style=\"fixed-case\">HBV DNA<\/jats:styled-content> and with <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> genotype B, but not with liver fibrosis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/liv.12222","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T05:44:07Z","timestamp":1368769447000},"page":"1363-1369","source":"Crossref","is-referenced-by-count":20,"title":["Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres"],"prefix":"10.1111","volume":"33","author":[{"given":"Stephen E.","family":"Congly","sequence":"first","affiliation":[{"name":"Liver Unit Division of Gastroenterology and Hepatology University of Calgary Calgary AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Wong","sequence":"additional","affiliation":[{"name":"McGill University Health Centre Royal Victoria Hospital Montreal QC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said A.","family":"Al\u2010Busafi","sequence":"additional","affiliation":[{"name":"McGill University Health Centre Royal Victoria Hospital Montreal QC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Doucette","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases University of Alberta Edmonton AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott K.","family":"Fung","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Toronto Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ghali","sequence":"additional","affiliation":[{"name":"McGill University Health Centre Royal Victoria Hospital Montreal QC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Alberta Provincial Laboratory of Public Health Calgary AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Myers","sequence":"additional","affiliation":[{"name":"Liver Unit Division of Gastroenterology and Hepatology University of Calgary Calgary AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Osiowy","sequence":"additional","affiliation":[{"name":"Bloodborne Pathogens and Hepatitis Section National Microbiology Laboratory Winnipeg MB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla S.","family":"Coffin","sequence":"additional","affiliation":[{"name":"Liver Unit Division of Gastroenterology and Hepatology University of Calgary Calgary AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,14]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-69-10-2575"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-73-5-1201"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1702(95)00069-0"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01326.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06541.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00584.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33588"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70261-7"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji043"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21188"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.08.061"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.37041"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50352"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00700-5"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21563"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2008.01045.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1086\/509894"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1155\/2001\/790915"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044611"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01297.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01356.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.01.014"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2010.12.008"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.04.005"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25718"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/506819"},{"key":"e_1_2_6_28_1","first-page":"103","article-title":"Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): usefulness in patients with chronic liver disease: APRI in chronic liver disease","volume":"11","author":"Yilmaz Y","year":"2011","journal-title":"Hepat Mon"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2007.10.011"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1659-1"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.12.5473-5477.2003"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05122-11"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05454-11"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.01.007"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00691.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir495"},{"key":"e_1_2_6_37_1","unstructured":"Statistics Canada.Census of Population Statistics Canada catalogue no. 97\u2010562\u2010XCB2006006(British Columbia\/Colombie\u2010Britannique Code59).2006."},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir282"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23905"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.07.046"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22760"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04973.x"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23722"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12044"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1458"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01486.x"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.01.028"},{"key":"e_1_2_6_48_1","first-page":"74","article-title":"Prevalence of genotype and lamivudine resistance in hepatitis B viruses in British Columbia from 2000 to 2005","volume":"17","author":"McNabb A","year":"2006","journal-title":"Can J Infect Dis Med Microbiol"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.12222","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.12222","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.12222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T07:00:14Z","timestamp":1696489214000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.12222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,14]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1111\/liv.12222"],"URL":"https:\/\/doi.org\/10.1111\/liv.12222","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,14]]}}}